Aviptadil
Synthetic vasoactive intestinal peptide (VIP) analog API with multi-target therapeutic potential. Potent VIP receptor activation delivering lung protection, vasodilation, anti-inflammation, and immunomodulation.
Aviptadil, also known as RLF-100 or ZYESAMI, is a synthetic form of Vasoactive Intestinal Peptide (VIP), a 28-amino acid linear polypeptide that acts as a neurotransmitter in the central and enteric nervous systems. Aviptadil is structurally identical to human VIP and exerts potent vasodilatory, anti-inflammatory, and cytoprotective effects by binding to VPAC1 and VPAC2 receptors distributed throughout the body.
| CAS | 40077-57-4 |
| Molecular Formula | C₁₄₇H₂₃₈N₄₄O₄₂S |
| Molecular Weight | 3325.80 g/mol |
| Category | Cardiovascular & Coagulation Peptides |
| Purity | >=99% (HPLC) |
| Status | GMP-compliant, FDA-ready |
| Applications | Acute respiratory distress syndrome, pulmonary hypertension, severe lung infection, erectile dysfunction |
| CAS | 40077-57-4 |
|---|---|
| Applications | Acute respiratory distress syndrome, ARDS, Lung protection, Pulmonary hypertension, VIP analog |




